Structural characterization of low molecular weight heparins
- PMID: 10549712
Structural characterization of low molecular weight heparins
Abstract
Low molecular weight heparins (LMWHs) obtained by different depolymerization processes can be distinguished from each other by characteristic end-residues, which are easily identified and quantified by nuclear-magnetic-resonance (NMR) spectroscopy. NMR spectroscopy characterizes major sulfation patterns as well as minor sequences such as the antithrombin-binding sequence and the linkage region of LMWHs. Artifacts associated with base-induced modifications such as the formation of iduronic acid epoxide and aziridine derivatives of N-sulfoglucosamine residues can also be detected. The influence of these modifications on the binding of heparins and LMWHs to proteins other than antithrombin are discussed.
Similar articles
-
Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy.Semin Thromb Hemost. 2007 Jul;33(5):478-87. doi: 10.1055/s-2007-982078. Semin Thromb Hemost. 2007. PMID: 17629844 Review.
-
Structural modification induced in heparin by a Fenton-type depolymerization process.Semin Thromb Hemost. 2007 Jul;33(5):466-77. doi: 10.1055/s-2007-982077. Semin Thromb Hemost. 2007. PMID: 17629843 Review.
-
Variability of heparins and heterogeneity of low molecular weight heparins.Semin Thromb Hemost. 2007 Jul;33(5):496-502. doi: 10.1055/s-2007-982080. Semin Thromb Hemost. 2007. PMID: 17629846 Review.
-
Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation.Arzneimittelforschung. 2001 Oct;51(10):806-13. doi: 10.1055/s-0031-1300119. Arzneimittelforschung. 2001. PMID: 11715633
-
Production and chemical processing of low molecular weight heparins.Semin Thromb Hemost. 1999;25 Suppl 3:5-16. Semin Thromb Hemost. 1999. PMID: 10549711 Review.
Cited by
-
Monitoring of heparin and its low-molecular-weight analogs by silicon field effect.Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13374-9. doi: 10.1073/pnas.0604471103. Epub 2006 Aug 28. Proc Natl Acad Sci U S A. 2006. PMID: 16938875 Free PMC article.
-
Update on the safety and bioequivalence of biosimilars - focus on enoxaparin.Drug Healthc Patient Saf. 2013 Jun 10;5:133-41. doi: 10.2147/DHPS.S28813. Print 2013. Drug Healthc Patient Saf. 2013. PMID: 23788840 Free PMC article.
-
Identification of a novel structure in heparin generated by potassium permanganate oxidation.Carbohydr Polym. 2010 Oct 15;82(3):699-705. doi: 10.1016/j.carbpol.2010.05.038. Carbohydr Polym. 2010. PMID: 25147414 Free PMC article.
-
Characterization of anticoagulant heparinoids by immunoprofiling.Glycoconj J. 2008 Feb;25(2):177-85. doi: 10.1007/s10719-007-9070-z. Epub 2007 Oct 2. Glycoconj J. 2008. PMID: 17909966 Free PMC article.
-
Antithrombin-binding oligosaccharides: structural diversities in a unique function?Glycoconj J. 2014 Oct;31(6-7):409-16. doi: 10.1007/s10719-014-9543-9. Glycoconj J. 2014. PMID: 25145542
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources